Rybrevant vs. Rybrevant Faspro for Lung Cancer: Important Differences and Potential Risks.

Rybrevant

(amivantamab)

Rybrevant Faspro

(amivantamab / hyaluronidase)

Summary for Rybrevant

Prescription only

Rybrevant (amivantamab-vmjw) is an FDA approved injection used to treat adults with non-small cell lung cancer (NSCLC) that has certain EGFR mutations. It's given as an infusion through your vein (IV), and your dosing schedule depends on the type of lung cancer being treated. You also might receive it with other cancer medications. Common side effects include infusion-related reactions, rash, tiredness, and skin infections around the nails.

Indications for Rybrevant

Adults with advanced or metastatic NSCLC with certain EGFR mutations:

Used with lazertinib as a first-choice treatment
Used with carboplatin and pemetrexed if the cancer has gotten worse or it didn't respond well to EGFR inhibitors
Used with carboplatin and pemetrexed as a first-choice treatment
Used alone if the cancer has gotten worse or didn't respond well to platinum-based chemotherapy

Pros and Cons for Rybrevant

Pros

Recommended option for NSCLC for certain adults
Works in a more targeted way than traditional chemotherapy
Typically given every 1 to 3 weeks

Cons

Commonly causes rash and nail problems
Needs to be infused through the vein at a clinic or hospital
Long infusion times, especially for the first few treatments

Common Side Effects for Rybrevant

Used with lazertinib:

Rash
Infected skin around the nail
Muscle and joint pain
Mouth sores
Swelling
Tingling sensation
Tiredness
Diarrhea
Constipation
COVID-19
Dry skin
Bleeding
Reduced appetite
Itchy skin
Nausea
Changes in certain blood tests

Used with carboplatin and pemetrexed:

Rash
Infected skin around the nail
Tiredness
Nausea
Mouth sores
Constipation
Swelling
Reduced appetite
Muscle and joint pain
Vomiting
COVID-19
Changes in certain blood tests

Used alone:

Rash
Infected skin around the nail
Muscle and joint pain
Shortness of breath
Nausea
Tiredness
Swelling
Mouth sores
Cough
Constipation
Vomiting
Changes in certain blood tests

Warnings for Rybrevant

Infusion-related reactions
Lung problems
Blood clots (when used with lazertinib)
Skin problems
Eye problems
Harm to the unborn baby

Summary for Rybrevant Faspro

Prescription only

Rybrevant Faspro (amivantamab-vmjw / hyaluronidase-vhjc) is a combination medication used to treat adults with non-small cell lung cancer (NSCLC) that have specific EGFR mutations. The medication is injected under the skin in your stomach by a healthcare professional. Depending on your treatment plan, you might receive it alone or with other cancer medications. Common side effects include rash, muscle or joint pain, and skin infections around the nails.

Indications for Rybrevant Faspro

Used with lazertinib as a first-choice treatment
Used with carboplatin and pemetrexed if the cancer has gotten worse or it didn't respond well to EGFR inhibitors
Used with carboplatin and pemetrexed as a first-choice treatment
Used alone if the cancer has gotten worse or didn't respond well to platinum-based chemotherapy

Pros and Cons for Rybrevant Faspro

Pros

Recommended option for NSCLC for certain adults
Given as an injection under the skin instead of an IV infusion
Typically given every 1 to 3 weeks

Cons

Must be given by a healthcare professional
Commonly causes rash and nail problems
Can cause serious lung and skin side effects

Common Side Effects for Rybrevant Faspro

Used with lazertinib:

Rash (80%)
Infected skin around the nail (58%)
Muscle and joint pain (50%)
Tiredness (37%)
Mouth sores (36%)
Swelling (34%)
Nausea (30%)
Diarrhea (22%)
Vomiting (22%)
Constipation (22%)
Reduced appetite (22%)
Headache (21%)
Changes in certain blood tests

Note: Side effects might differ if you use Rybrevant Faspro (amivantamab / hyaluronidase) alone or with chemotherapy

Warnings for Rybrevant Faspro

Allergic and injection-related reactions
Lung problems
Blood clots (when used with lazertinib)
Skin problems
Eye problems
Harm to unborn babies

Prices with our coupons for Rybrevant vs. Rybrevant Faspro

Rybrevant5 vials / 7ml of 350mg/7ml

Get free coupons

More Information

Rybrevant Faspro10 vials / 1600mg of 20000 units/10ml

Get free coupons

More Information

Compare other Lung Cancer drugs

Rybrevant vs. Tagrisso Imfinzi vs. Keytruda Jemperli vs. Keytruda Keytruda vs. Opdivo Keytruda vs. Tecentriq

Libtayo vs. Keytruda Tagrisso vs. Keytruda

Browse medications by letter

Show All

Browse prescription and over-the-counter medications from A to Z, compare drug prices, and start saving.

Compare
Rybrevant vs. Rybrevant Faspro

Rybrevant

Rybrevant Faspro

Summary for Rybrevant

Indications for Rybrevant

Pros and Cons for Rybrevant

Pros

Cons

Common Side Effects for Rybrevant

Warnings for Rybrevant

Summary for Rybrevant Faspro

Indications for Rybrevant Faspro

Pros and Cons for Rybrevant Faspro

Pros

Cons

Common Side Effects for Rybrevant Faspro

Warnings for Rybrevant Faspro

Prices with our coupons for Rybrevant vs. Rybrevant Faspro

Compare other Lung Cancer drugs

Browse medications by letter

Good news for your inbox

Rybrevant

Rybrevant Faspro

Summary for Rybrevant

Indications for Rybrevant

Pros and Cons for Rybrevant

Pros

Cons

Common Side Effects for Rybrevant

Warnings for Rybrevant

Summary for Rybrevant Faspro

Indications for Rybrevant Faspro

Pros and Cons for Rybrevant Faspro

Pros

Cons

Common Side Effects for Rybrevant Faspro

Warnings for Rybrevant Faspro